1B6X
 
 | | 3,N4-ETHENO-2'-DEOXYCYTIDINE OPPOSITE GUANINE IN AN 11-MER DUPLEX, SOLUTION STRUCTURE FROM NMR AND MOLECULAR DYNAMICS, 4 STRUCTURES | | Descriptor: | 5'-D(*CP*GP*TP*AP*CP*(EDC)P*CP*AP*TP*GP*C)-3', 5'-D(*GP*CP*AP*TP*GP*GP*GP*TP*AP*CP*G)-3' | | Authors: | Cullinan, D, Johnson, F, Grollman, A.P, Eisenberg, M, De Los Santos, C. | | Deposit date: | 1999-01-19 | | Release date: | 1999-01-27 | | Last modified: | 2024-04-10 | | Method: | SOLUTION NMR | | Cite: | Solution structure of a DNA duplex containing the exocyclic lesion 3,N4-etheno-2'-deoxycytidine opposite 2'-deoxyguanosine.
Biochemistry, 36, 1997
|
|
1B60
 | | 3,N4-ETHENO-2'-DEOXYCYTIDINE OPPOSITE CYTIDINE IN AN 11-MER DUPLEX, SOLUTION STRUCTURE FROM NMR AND MOLECULAR DYNAMICS | | Descriptor: | DNA (5'-D(*CP*GP*TP*AP*CP*(EDC)P*CP*AP*TP*GP*C)-3'), DNA (5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3') | | Authors: | Cullinan, D, Johnson, F, De Los Santos, C. | | Deposit date: | 1999-01-20 | | Release date: | 2000-02-18 | | Last modified: | 2023-12-27 | | Method: | SOLUTION NMR | | Cite: | Solution structure of an 11-mer duplex containing the 3, N(4)-ethenocytosine adduct opposite 2'-deoxycytidine: implications for the recognition of exocyclic lesions by DNA glycosylases.
J.Mol.Biol., 296, 2000
|
|
1EXL
 | | STRUCTURE OF AN 11-MER DNA DUPLEX CONTAINING THE CARBOCYCLIC NUCLEOTIDE ANALOG: 2'-DEOXYARISTEROMYCIN | | Descriptor: | DNA (5'-D(*CP*AP*GP*TP*GP*(2AR)P*GP*TP*CP*AP*C)-3'), DNA (5'-D(*GP*TP*GP*AP*CP*TP*CP*AP*CP*TP*G)-3') | | Authors: | Smirnov, S, Johnson, F, Marumoto, R, de los Santos, C. | | Deposit date: | 2000-05-03 | | Release date: | 2000-05-15 | | Last modified: | 2024-05-01 | | Method: | SOLUTION NMR | | Cite: | Structure of an 11-mer DNA duplex containing the carbocyclic nucleotide analog: 2'-deoxyaristeromycin
J.Biomol.Struct.Dyn., 17, 2000
|
|
1FJB
 | | NMR Study of an 11-Mer DNA Duplex Containing 7,8-Dihydro-8-Oxoadenine (AOXO) Opposite Thymine | | Descriptor: | DNA (5'-D(*CP*GP*TP*AP*CP*(A38)P*CP*AP*TP*GP*C)-3'), DNA (5'-D(*GP*CP*AP*TP*GP*TP*GP*TP*AP*CP*G)-3') | | Authors: | Chen, H, Johnson, F, Grollman, A.P, Patel, D.J. | | Deposit date: | 1995-12-15 | | Release date: | 1996-06-10 | | Last modified: | 2024-05-22 | | Method: | SOLUTION NMR | | Cite: | Structural Studies of the Ionizing Radiation Adduct 7,8-Dihydro-8-Oxoadenine (A Oxo) Positioned Opposite Thymine and Guanine in DNA Duplexes
MAGN.RESON.CHEM., 34, 1996
|
|
1FYI
 | |
2B36
 | | Crystal structure of Mycobacterium tuberculosis enoyl reductase (InhA) inhibited by 5-pentyl-2-phenoxyphenol | | Descriptor: | 5-PENTYL-2-PHENOXYPHENOL, Enoyl-[acyl-carrier-protein] reductase [NADH], NICOTINAMIDE-ADENINE-DINUCLEOTIDE | | Authors: | Sullivan, T.J, Truglio, J.J, Novichenok, P, Stratton, C, Zhang, X, Kaur, T, Johnson, F, Boyne, M.S, Amin, A. | | Deposit date: | 2005-09-19 | | Release date: | 2006-03-07 | | Last modified: | 2024-02-14 | | Method: | X-RAY DIFFRACTION (2.8 Å) | | Cite: | High Affinity InhA Inhibitors with Activity against Drug-Resistant Strains
of Mycobacterium tuberculosis
ACS Chem.Biol., 1, 2006
|
|
2B35
 | | Crystal structure of Mycobacterium tuberculosis enoyl reductase (InhA) inhibited by triclosan | | Descriptor: | Enoyl-[acyl-carrier-protein] reductase [NADH], NICOTINAMIDE-ADENINE-DINUCLEOTIDE, TRICLOSAN | | Authors: | Sullivan, T.J, Truglio, J.J, Novichenok, P, Stratton, C, Zhang, X, Kaur, T, Johnson, F, Boyne, M.S, Amin, A. | | Deposit date: | 2005-09-19 | | Release date: | 2006-03-07 | | Last modified: | 2024-02-14 | | Method: | X-RAY DIFFRACTION (2.3 Å) | | Cite: | High Affinity InhA Inhibitors with Activity against Drug-Resistant Strains
of Mycobacterium tuberculosis
ACS Chem.Biol., 1, 2006
|
|
2B37
 | | Crystal structure of Mycobacterium tuberculosis enoyl reductase (InhA) inhibited by 5-octyl-2-phenoxyphenol | | Descriptor: | 5-OCTYL-2-PHENOXYPHENOL, Enoyl-[acyl-carrier-protein] reductase [NADH], NICOTINAMIDE-ADENINE-DINUCLEOTIDE | | Authors: | Sullivan, T.J, Truglio, J.J, Novichenok, P, Stratton, C, Zhang, X, Kaur, T, Johnson, F, Boyne, M.S, Amin, A. | | Deposit date: | 2005-09-19 | | Release date: | 2006-03-07 | | Last modified: | 2024-02-14 | | Method: | X-RAY DIFFRACTION (2.6 Å) | | Cite: | High Affinity InhA Inhibitors with Activity against Drug-Resistant Strains
of Mycobacterium tuberculosis
ACS Chem.Biol., 1, 2006
|
|
1XCZ
 | | Structure of DNA containing the beta-anomer of a carbocyclic abasic site | | Descriptor: | 5'-D(*CP*GP*TP*AP*CP*(DXD)P*CP*AP*TP*GP*C)-3', 5'-D(*GP*CP*AP*TP*GP*AP*GP*TP*AP*CP*G)-3' | | Authors: | de los Santos, C, El-khateeb, M, Rege, P, Tian, K, Johnson, F. | | Deposit date: | 2004-09-03 | | Release date: | 2004-10-19 | | Last modified: | 2024-05-22 | | Method: | SOLUTION NMR | | Cite: | Impact of the C1 configuration of abasic sites on DNA duplex structure
Biochemistry, 43, 2004
|
|
1XCY
 | | Structure of DNA containing the alpha-anomer of a carbocyclic abasic site | | Descriptor: | 5'-D(*CP*GP*TP*AP*CP*(DXD)P*CP*AP*TP*GP*C)-3', 5'-D(*GP*CP*AP*TP*GP*AP*GP*TP*AP*CP*G)-3' | | Authors: | de los Santos, C, El-khateeb, M, Rege, P, Tian, K, Johnson, F. | | Deposit date: | 2004-09-03 | | Release date: | 2004-10-19 | | Last modified: | 2024-05-22 | | Method: | SOLUTION NMR | | Cite: | Impact of the C1 configuration of abasic sites on DNA duplex structure
Biochemistry, 43, 2004
|
|
2LWN
 | | Solution Structure of Duplex DNA Containing a b-Carba-Fapy-dG Lesion | | Descriptor: | DNA (5'-D(*CP*GP*TP*AP*C*(LWM)P*CP*AP*TP*GP*C)-3'), DNA (5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3') | | Authors: | Zalianyak, T, de los Santos, C, Lukin, M, Attaluri, S, Johnson, F. | | Deposit date: | 2012-08-03 | | Release date: | 2013-02-20 | | Last modified: | 2024-05-01 | | Method: | SOLUTION NMR | | Cite: | Solution Structure of Duplex DNA Containing a b-Carba-Fapy-dG Lesion
Chem.Res.Toxicol., 25, 2012
|
|
2LWM
 | | Solution Structure of Duplex DNA Containing a b-Carba-Fapy-dG Lesion | | Descriptor: | DNA (5'-D(*CP*GP*TP*AP*C*(LWM)P*CP*AP*TP*GP*C)-3'), DNA (5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3') | | Authors: | Zalianyak, T, de los Santos, C, Lukin, M, Attaluri, S, Johnson, F. | | Deposit date: | 2012-08-03 | | Release date: | 2013-02-20 | | Last modified: | 2024-05-01 | | Method: | SOLUTION NMR | | Cite: | Solution Structure of Duplex DNA Containing a b-Carba-Fapy-dG Lesion
Chem.Res.Toxicol., 25, 2012
|
|
2LWO
 | | Solution Structure of Duplex DNA Containing a b-Carba-Fapy-dG Lesion | | Descriptor: | DNA (5'-D(*G*CP*GP*TP*AP*C*(LWM)P*CP*AP*TP*GP*C)-3'), DNA (5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3') | | Authors: | Zalianyak, T, de los Santos, C, Lukin, M, Attaluri, S, Johnson, F. | | Deposit date: | 2012-08-03 | | Release date: | 2013-02-20 | | Last modified: | 2024-05-01 | | Method: | SOLUTION NMR | | Cite: | Solution Structure of Duplex DNA Containing a b-Carba-Fapy-dG Lesion
Chem.Res.Toxicol., 25, 2012
|
|
2K1Y
 | | Solution Structure of Duplex DNA Containing the Mutagenic Lesion: 1,N2-Etheno-2'-deoxyguanine | | Descriptor: | 5'-D(*DCP*DGP*DTP*DAP*DCP*(GNE)P*DCP*DAP*DTP*DGP*DC)-3', 5'-D(*DGP*DCP*DAP*DTP*DGP*DCP*DGP*DTP*DAP*DCP*DG)-3' | | Authors: | Zaliznyak, T, Lukin, M, Johnson, F, de los Santos, C. | | Deposit date: | 2008-03-18 | | Release date: | 2009-02-03 | | Last modified: | 2024-05-29 | | Method: | SOLUTION NMR | | Cite: | Solution structure of duplex DNA containing the mutagenic lesion 1,N(2)-etheno-2'-deoxyguanine.
Biochemistry, 47, 2008
|
|
2KDA
 | | Solution Structure of DNA Containing Alpha-OH-PdG: the Mutagenic Adduct Produced by Acrolein | | Descriptor: | 5'-D(*CP*GP*TP*AP*CP*(63H)P*CP*AP*TP*GP*C)-3', 5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3' | | Authors: | de los Santos, C, Zaliznyak, T, Johnson, F, Bonala, R, Attaluri, S. | | Deposit date: | 2009-01-05 | | Release date: | 2009-04-21 | | Last modified: | 2024-05-22 | | Method: | SOLUTION NMR | | Cite: | Solution structure of DNA containing alpha-OH-PdG: the mutagenic adduct produced by acrolein.
Nucleic Acids Res., 37, 2009
|
|
2LSZ
 | | NMR structure of duplex DNA containing the alpha-OH-PdG dA base pair: A mutagenic intermediate of acrolein | | Descriptor: | DNA (5'-D(*CP*GP*TP*AP*CP*(63H)P*CP*AP*TP*GP*C)-3'), DNA (5'-D(*GP*CP*AP*TP*GP*AP*GP*TP*AP*CP*G)-3') | | Authors: | Zaliznyak, T, de los Santos, C, Lukin, M, El-khateeb, M, Bonala, R, Johnson, F. | | Deposit date: | 2012-05-09 | | Release date: | 2012-06-13 | | Last modified: | 2024-05-01 | | Method: | SOLUTION NMR | | Cite: | NMR structure of duplex DNA containing the alpha-OH-PdG.dA base pair: a mutagenic intermediate of acrolein.
Biopolymers, 93, 2010
|
|
2KD9
 | | Solution Structure of DNA Containing Alpha-OH-PdG: the Mutagenic Adduct Produced by Acrolein | | Descriptor: | 5'-D(*CP*GP*TP*AP*CP*(63G)P*CP*AP*TP*GP*C)-3', 5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3' | | Authors: | de los Santos, C, Zaliznyak, T, Johnson, F, Bonala, R, Attaluri, S. | | Deposit date: | 2009-01-05 | | Release date: | 2009-04-21 | | Last modified: | 2024-05-22 | | Method: | SOLUTION NMR | | Cite: | Solution structure of DNA containing alpha-OH-PdG: the mutagenic adduct produced by acrolein.
Nucleic Acids Res., 37, 2009
|
|
2LT0
 | | NMR structure of duplex DNA containing the beta-OH-PdG dA base pair: A mutagenic intermediate of acrolein | | Descriptor: | DNA (5'-D(*CP*GP*TP*AP*CP*(63G)P*CP*AP*TP*GP*C)-3'), DNA (5'-D(*GP*CP*AP*TP*GP*AP*GP*TP*AP*CP*G)-3') | | Authors: | Zaliznyak, T, de los Santos, C, Lukin, M, El-khateeb, M, Bonala, R, Johnson, F. | | Deposit date: | 2012-05-09 | | Release date: | 2012-06-13 | | Last modified: | 2024-05-01 | | Method: | SOLUTION NMR | | Cite: | NMR structure of duplex DNA containing the alpha-OH-PdG.dA base pair: a mutagenic intermediate of acrolein.
Biopolymers, 93, 2010
|
|
2LGM
 | | Structure of DNA Containing an Aristolactam II-dA Lesion | | Descriptor: | DNA (5'-D(*CP*GP*TP*AP*CP*AP*CP*AP*TP*GP*C)-3'), DNA (5'-D(*GP*CP*AP*TP*GP*TP*GP*TP*AP*CP*G)-3'), [1,3]benzodioxolo[6,5,4-cd]benzo[f]indol-5(6H)-one | | Authors: | Lukin, M, Zaliznyak, T, Johnson, F, de los Santos, C. | | Deposit date: | 2011-07-28 | | Release date: | 2011-11-30 | | Last modified: | 2024-05-15 | | Method: | SOLUTION NMR | | Cite: | Structure and stability of DNA containing an aristolactam II-dA lesion: implications for the NER recognition of bulky adducts.
Nucleic Acids Res., 40, 2012
|
|
